当前位置:
X-MOL 学术
›
J. Clin. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient.
Journal of Clinical Immunology ( IF 7.2 ) Pub Date : 2020-09-17 , DOI: 10.1007/s10875-020-00864-w Oliver Wegehaupt 1, 2 , Tina Muckenhaupt 3 , Matthew B Johnson 4 , Karl Otfried Schwab 5 , Carsten Speckmann 1, 2
中文翻译:
Ruxolitinib 控制 STAT3-GOF 患者的淋巴增殖和糖尿病。
更新日期:2020-09-17
Journal of Clinical Immunology ( IF 7.2 ) Pub Date : 2020-09-17 , DOI: 10.1007/s10875-020-00864-w Oliver Wegehaupt 1, 2 , Tina Muckenhaupt 3 , Matthew B Johnson 4 , Karl Otfried Schwab 5 , Carsten Speckmann 1, 2
Affiliation
中文翻译:
Ruxolitinib 控制 STAT3-GOF 患者的淋巴增殖和糖尿病。